Sources Sought for Small Businesses - IgE Testing
Closed Pre-Solicitation Posted
A newer special notice was posted. See the latest special notice from .
- Solicitation number
- NHANESIgE
- Agency
- CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
-
- Michael Gilham ueh8@cdc.gov (301) 458-4598
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) is conducting market research for a potential small business contract to provide CLIA-certified laboratory services to measure total and allergen-specific immunoglobulin E (IgE) levels from biological samples collected through the National Health and Nutrition Examination Survey (NHANES). The key objectives are to test approximately 3,600-5,000 samples annually for 21 allergen-specific IgEs and 7 optional food-specific IgEs using Fluorescent Enzyme Immunoassay (FEIA), develop and deliver laboratory procedure manuals, and complete any required crossover studies. Responses are due by 4pm Eastern Time on October 21, 2024 via email to the points of contact, demonstrating the responding small business's capability to meet the requirements detailed in the attached Statement of Work.
This is a pre-solicitation notice, not a solicitation, and no contract will be awarded based on the responses. There is no set-aside designation. The period of performance is from January 1, 2025 to December 31, 2029, with 5 option years. The NAICS code is 621511 - Medical Laboratories, and the PSC is Q301-P - Reference Laboratory Testing. The procuring agency is the Department of Health and Human Services, Centers for Disease Control and Prevention, Office of Acquisition Services.
Notice text
This is not a solicitation or request for quote and there will be no contract awarded relative to this notice. The CDC is conducting market research to determine the availability of small businesses to inform its acquisition method. If your responsible small business is capable of meeting the requirements detailed in the attached Statement of Work for testing of allergen-specific levels of immunoglobulin E (IgE), please send a summary of capabilities that demonstrates such for review.
Responses are due by 4pm Eastern Time on October 21, 2024 via email to Michael Gilham at ueh8@cdc.gov.
Attachments
| File | Type | Posted |
|---|---|---|
| SOW IgE.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Intent to Single Source Open Market Items for Admin. Convenience | Special Notice | |
| Sources Sought for Small Businesses - IgE Testing | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity